Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)Tricia R. Cottrell, Janis M. Taube, Patrick M. Forde et al.|Annals of Oncology|2018Cited by 588
Implications of the tumor immune microenvironment for staging and therapeuticsJanis M. Taube, Ashley Cimino‐Mathews|Modern Pathology|2017Cited by 364